- Home
- GENK vs EVOK Comparison
GENK vs EVOK Comparison
Compare GENK & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GENK | EVOK |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3M | 18.4M |
| IPO Year | 2023 | 2013 |
Fundamental Metrics
Financial Performance| Metric | GENK | EVOK |
|---|---|---|
| Price | $2.25 | $10.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 52.5K | 30.4K |
| Earning Date | 11-07-2025 | 11-13-2025 |
| Dividend Yield | ★ 1.29% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $217,449,000.00 | $14,424,652.00 |
| Revenue This Year | $11.49 | $58.96 |
| Revenue Next Year | $13.34 | $57.99 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 9.36 | ★ 67.40 |
| 52 Week Low | $2.20 | $1.94 |
| 52 Week High | $8.45 | $10.99 |
Technical Indicators
Market Signals| Indicator | GENK | EVOK |
|---|---|---|
| Relative Strength Index (RSI) | 35.36 | 84.91 |
| Support Level | $2.20 | $10.66 |
| Resistance Level | $2.41 | $10.99 |
| Average True Range (ATR) | 0.15 | 0.05 |
| MACD | 0.01 | -0.19 |
| Stochastic Oscillator | 8.97 | 93.10 |
Price Performance
Historical ComparisonAbout GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.